CanTx Overview

  • Founded
  • 2013
Founded
  • Status
  • Private
  • Latest Deal Type
  • Joint Venture
  • Financing Rounds
  • 1

CanTx General Information

Description

Developer of ovarian cancer drug. The company develops drugs which destroys the cancer stem cells.

Contact Information

Website
Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Primary Office
  • New Haven, CT
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

CanTx Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore CanTx‘s full profile, request access.

Request a free trial

CanTx Executive Team (3)

Name Title Board Seat Contact Info
David Brown Ph.D Chief Scientific Officer
Andrew Heaton Ph.D Vice President, Drug Discovery
Graham Kelly Ph.D Founder
To view CanTx’s complete executive team members history, request access »

CanTx Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore CanTx‘s full profile, request access.

Request a free trial